Skip to main content
Nicholas Butowski, MD, Neurology, San Francisco, CA

NicholasAButowskiMD

Neurology San Francisco, CA

Neurooncology

Professor of Clinical Neurological Surgery, UCSF School of Medicine

Dr. Butowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Butowski's full profile

Already have an account?

  • Office

    400 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-353-2996
    Fax+1 415-353-2167

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Neuro-Oncology, 2003 - 2004
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 2000 - 2003
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 1999 - 2000
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1999, MD
  • Northwestern University
    Northwestern UniversityBA, Philosophy/Religion, 1991 - 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Essential Core Teaching Award UCSF, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Voice of the Patient Award UCSF, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Genetic Landscape of Gliomas Arising After Therapeutic Radiation  
    Iwei Yeh, Corey Raffel, Mitchel Berger, Joanna J Phillips, James P Grenert, Boris C Bastian, David A Solomon, Nicholas Butowski, Sabine Mueller, Cassie Kline, Manish A..., Acta Neuropathologica
  • A Single-institution Phase II Trial of Radiation, Temozolomide, Erlotinib, and Bevacizumab for Initial Treatment of Glioblastoma  
    Clarke, J.L., Molinaro, A.M., Butowski, N.A., Chang, S.M., Phillips, J.J., Perry, A., Costello, J.F., DeSilva, A.A., Rabbitt, J.E., Prados, M.D., Neuro Oncol., 1/1/2014
  • General and Neurological Complications of Targeted Therapy  
    Butowski NA, Chang SM, Handbook of Clinical Neurology, 1/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioblastoma Multiforme (GBM).
    Kent C. Shih, Manish R. Patel, Nicholas A. Butowski, Jeffrey A. Bacha, Dennis Brown, William J. Garner, Anne Steino, Richard Stephen Schwartz, Sarath Kanekal, Lorena L..., ASCO Annual Meeting, 1/1/2014
  • A Phase 2 Study of Orally Administered PLX3397 in Patients With Recurrent Glioblastoma
    N. Butowski, H. Colman, J. DeGroot A. Yung, A. Omuro, L. Nayak, T. Cloughsey, A. Marimuthu, A. Perry , J. Phillips , J. Joyce , B. L. West , M. Prados , K. Nolop, H..., ASCO Annual Meeting, 1/1/2014
  • OMX-4.80 An Engineered Oxygen Carryig Protein Oxygenetes Hypoxic Tumors and Increase the Efficacy of Radiotherapy in Orthotopic Models of Glioblastoma
    Laura Serwer, Raquel Santos, Saharh Ng, Nicholas Butowski, Ana Krloitica, Tomoko OZawa, Stephen Cary, David James, World Federation of Neuro-Oncology Quadrennial Meeting, San Francisco, CA, 1/1/2014
  • Join now to see all

Lectures

  • DGM1 may serve as a novel genetic biomarker of response to enzastaurin in glioblastoma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • ICBTRT: International Conference on Brain Tumor Research and Therapy 
    1/1/2014
  • Overcoming Tumour Hypoxia to Enhance Patient Survival With a Tunable Oxygen-Binding Protein Therapy 
    United Kingdom - 1/1/2014
  • Join now to see all

Press Mentions

  • A Brain Tumor Patient Celebrates Survival
    A Brain Tumor Patient Celebrates SurvivalJune 14th, 2022
  • DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
    DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083November 5th, 2019
  • DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
    DelMar Pharmaceuticals Announces Expansion of Scientific Advisory BoardMay 20th, 2019
  • Join now to see all

Professional Memberships